HMGB1 and pulmonary fibrosis: In summary, we comprehensively investigated the role of the molecule HMGB1, the involvement of oxidation-antioxidant unbalance, and the related molecule transduction mechanism downstream of gefitinib treatment in bleomycin-induced pulmonary fibrosis.